Three Essays on Prescription Drug Insurance Benefit Design: The Effects of Prescription Drug Cost-Sharing on Health Spending, Compliance, and Health Outcome
Jian Li
Abstract
Jian Li
Abstract
In the past 15 years, national spending on prescription drugs has grown dramatically, outpacing the growth rate of hospital spending and physician spending in the same period. In response, many health insurance plans have reduced the generosity of their prescription drug benefits by imposing increasingly higher cost-sharing on patients' side for their pharmaceutical uses. This research paper contains in-depth evaluations of the impacts of prescription drug insurance benefit design on health spending, consumers' use of medical care, compliance with drug regimens, and health outcomes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In the past 15 years, national spending on prescription drugs has grown dramatically, outpacing the growth rate of hospital spending and physician spending in the same period. In response, many health insurance plans have reduced the generosity of their prescription drug benefits by imposing increasingly higher cost-sharing on patients' side for their pharmaceutical uses. This research paper contains in-depth evaluations of the impacts of prescription drug insurance benefit design on health spending, consumers' use of medical care, compliance with drug regimens, and health outcomes.
Key concepts: Medical prescription, Prescription drug, Drug, Compliance (psychology), Cost sharing, Medicine, Health insurance, Outcome (game theory)